<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04371861</url>
  </required_header>
  <id_info>
    <org_study_id>TIS2019-01</org_study_id>
    <nct_id>NCT04371861</nct_id>
  </id_info>
  <brief_title>Observational Study to Assess Transradial Access for Treatment in the Lower Extremities.</brief_title>
  <acronym>R2P Registry</acronym>
  <official_title>Prospective, Multi-center, Observational, Post-market Study to Assess the Safety and Procedural Success of Performing Transradial Access for Treatment of Atherosclerotic Lesions in the Lower Extremities.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Terumo Medical Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Terumo Medical Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to collect data on the complication rates and procedural success of
      using a transradial access approach to treat peripheral lesions in the lower extremities of a
      real world population.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 29, 2020</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Radial access site complications</measure>
    <time_frame>Procedure</time_frame>
    <description>Rates of occurrence in complications associated with transradial access.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Procedural Success</measure>
    <time_frame>Procedure</time_frame>
    <description>Successful completion of intended procedure with access complications and without conversion to femoral access.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Peripheral Arterial Disease</condition>
  <arm_group>
    <arm_group_label>Treatment of lower extremity lesion via transradial access.</arm_group_label>
    <description>Interventions performed are standard of care for treatment of a peripheral lesion.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Peripheral Artery Treatment</intervention_name>
    <description>Peripheral lesions may be treated by any standard of care methods of treatment.</description>
    <arm_group_label>Treatment of lower extremity lesion via transradial access.</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects planned to undergo treatment of a lower extremity lesion via transradial artery
        access.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Rutherford Category 2-5

          -  Subject scheduled for a transradial intervention to treat a lesion in the lower
             extremities.

          -  Willing to sign consent and agree to follow-up requirements.

        Exclusion Criteria:

          -  Previous failed transradial access attempt

          -  Presence of or planned dialysis fistula.

          -  Planned amputation

          -  Previous or planned transradial access intervention +/- 30 days

          -  Radial artery diameter &lt;2.5mm

          -  No palpable radial artery

          -  Established vasospastic disease

          -  Known allergy to contrast that cannot be managed

          -  Pregnant or lactating

          -  Mentally incompetent or a prisoner

          -  Currently participating in a clinical study that has not completed it's primary
             endpoint
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mehdi Shishehbor, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospitals, Cleveland, OH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Charis Sugden</last_name>
    <phone>908-514-6154</phone>
    <email>charis.sugden@terumomedical.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hinna Shahid</last_name>
    <email>hinna.shahid@terumomedical.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cardiovascular Institute of the South</name>
      <address>
        <city>Lafayette</city>
        <state>Louisiana</state>
        <zip>70503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julie Zannini</last_name>
    </contact>
    <investigator>
      <last_name>Ankur Lodha, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mercy Hospital</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <zip>65804</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark Schrader</last_name>
    </contact>
    <investigator>
      <last_name>Christopher Stout, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sorin Medical, Inc.</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joshua Berookhim</last_name>
    </contact>
    <investigator>
      <last_name>Justin Racliffe, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>April 29, 2020</study_first_submitted>
  <study_first_submitted_qc>April 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 1, 2020</study_first_posted>
  <last_update_submitted>July 1, 2020</last_update_submitted>
  <last_update_submitted_qc>July 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

